X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (84499) 84499
Newspaper Article (20178) 20178
Newsletter (8066) 8066
Magazine Article (876) 876
Web Resource (493) 493
Book Chapter (393) 393
Trade Publication Article (320) 320
Dissertation (205) 205
Transcript (164) 164
Book / eBook (94) 94
Conference Proceeding (88) 88
Publication (29) 29
Book Review (27) 27
Streaming Video (20) 20
Reference (17) 17
Journal / eJournal (4) 4
Government Document (2) 2
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
melanoma (75988) 75988
humans (54183) 54183
oncology (33317) 33317
cancer (31869) 31869
female (25301) 25301
male (22018) 22018
animals (20471) 20471
metastasis (20189) 20189
immunotherapy (19722) 19722
middle aged (16483) 16483
tumors (16232) 16232
mice (14781) 14781
melanoma - pathology (14011) 14011
research (13852) 13852
care and treatment (13740) 13740
aged (13639) 13639
adult (13114) 13114
skin cancer (12037) 12037
melanoma - drug therapy (11679) 11679
cancer therapies (11558) 11558
cell line, tumor (9655) 9655
melanoma - therapy (9372) 9372
apoptosis (8899) 8899
dermatology (8466) 8466
chemotherapy (8418) 8418
skin neoplasms - pathology (8033) 8033
immunology (7738) 7738
patients (7655) 7655
medical research (7494) 7494
expression (7420) 7420
clinical trials (7307) 7307
prognosis (7296) 7296
metastatic melanoma (7135) 7135
malignant-melanoma (6728) 6728
surgery (6705) 6705
drug therapy (6547) 6547
analysis (6495) 6495
therapy (6492) 6492
health aspects (6154) 6154
mutation (6080) 6080
proteins (6063) 6063
medicine, research & experimental (5833) 5833
aged, 80 and over (5534) 5534
lymphocytes (5464) 5464
treatment outcome (5406) 5406
cell biology (5404) 5404
survival (5393) 5393
gene expression (5182) 5182
mice, inbred c57bl (5132) 5132
antineoplastic agents - therapeutic use (4952) 4952
skin neoplasms - drug therapy (4876) 4876
melanoma - genetics (4875) 4875
melanoma - secondary (4866) 4866
breast cancer (4801) 4801
metastases (4679) 4679
melanoma - immunology (4635) 4635
lung cancer (4632) 4632
melanoma - metabolism (4532) 4532
antigens (4529) 4529
genetic aspects (4371) 4371
medicine (4351) 4351
melanoma - surgery (4229) 4229
studies (4217) 4217
pharmaceutical industry (4139) 4139
medical prognosis (4113) 4113
immune system (4084) 4084
cells (4053) 4053
neoplasm metastasis (3966) 3966
skin neoplasms - therapy (3957) 3957
dendritic cells (3946) 3946
kinases (3917) 3917
biochemistry & molecular biology (3900) 3900
pharmacology & pharmacy (3741) 3741
ipilimumab (3712) 3712
medicine & public health (3654) 3654
development and progression (3608) 3608
antineoplastic agents (3599) 3599
antineoplastic agents - pharmacology (3589) 3589
retrospective studies (3531) 3531
tumor cells, cultured (3522) 3522
radiotherapy (3506) 3506
t cells (3503) 3503
cytotoxicity (3494) 3494
neoplasm staging (3491) 3491
diagnosis (3471) 3471
skin (3395) 3395
melanoma - diagnosis (3387) 3387
melanoma - mortality (3372) 3372
antimitotic agents (3295) 3295
risk factors (3230) 3230
research article (3191) 3191
neoplasms - therapy (3183) 3183
immunohistochemistry (3166) 3166
melanoma - radiotherapy (3143) 3143
combined modality therapy (3092) 3092
oncology, experimental (3055) 3055
activation (3042) 3042
pathology (3031) 3031
deoxyribonucleic acid--dna (3021) 3021
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (30) 30
Online Resources - Online (22) 22
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (3) 3
Scarborough Hospital - General (2) 2
Scarborough Hospital - Online (2) 2
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
UTL at Downsview - May be requested (1) 1
UofT Schools - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (110844) 110844
German (1777) 1777
French (1033) 1033
Japanese (537) 537
Russian (536) 536
Chinese (224) 224
Spanish (216) 216
Polish (193) 193
Italian (132) 132
Czech (96) 96
Portuguese (92) 92
Hungarian (60) 60
Korean (60) 60
Dutch (56) 56
Swedish (40) 40
Turkish (30) 30
Danish (22) 22
Hebrew (20) 20
Finnish (18) 18
Romanian (17) 17
Norwegian (14) 14
Slovak (14) 14
Croatian (13) 13
Serbian (9) 9
Bulgarian (8) 8
Ukrainian (5) 5
Slovenian (3) 3
Bosnian (2) 2
Greek (2) 2
Icelandic (2) 2
Persian (2) 2
Catalan (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Cancer, ISSN 0959-8049, 2016, Volume 68, pp. 156 - 162
...) durvalumab in combination with radiotherapy (RT) in an expansion cohort of patients included in a phase 1/2 trial at our institution... 
Hematology, Oncology and Palliative Medicine | Immunoradiotherapy | Phase 2 | Phase 1 | Radiotherapy | Anti-PD-L1 | ABSCOPAL | ONCOLOGY | MECHANISMS | PATIENT | RADIATION-THERAPY | Lymphatic Metastasis - radiotherapy | Bone Neoplasms - therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Radiosurgery | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Transitional Cell - therapy | Liver Neoplasms - therapy | Eye Neoplasms - therapy | Chemoradiotherapy | Small Cell Lung Carcinoma - secondary | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Eye Neoplasms - pathology | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Survival Rate | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Brain Neoplasms - therapy | Radiotherapy, Conformal | Aged | Small Cell Lung Carcinoma - therapy | Melanoma - therapy | Biochemistry | Apoptosis
Journal Article
2002, ISBN 9780896038769, xvi, 389
Book
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1324 - 1334
Journal Article
The Journal of clinical investigation, ISSN 1558-8238, 2016, Volume 126, Issue 9, pp. 3447 - 3452
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 77, Issue 3, pp. 655 - 661
... standard of care, WBRT, is appropriate as the primary treatment of all patients with BMs instead of reserving WBRT for later salvage therapy, as needed... 
Radiology | Hematology, Oncology and Palliative Medicine | radiotherapy | Brain metastases | prognosis | stereotactic radiosurgery | COST-EFFECTIVENESS | PARTITIONING ANALYSIS RPA | RADIATION-THERAPY | TRIAL | ONCOLOGY | NEUROCOGNITIVE FUNCTION | RANDOMIZED PHASE-III | ACCELERATED-FRACTIONATION | SINGLE METASTASES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Carcinoma, Non-Small-Cell Lung - radiotherapy | Gastrointestinal Neoplasms | Prognosis | Age Factors | Humans | Middle Aged | Lung Neoplasms | Small Cell Lung Carcinoma - drug therapy | Small Cell Lung Carcinoma - secondary | Brain Neoplasms - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Karnofsky Performance Status | Small Cell Lung Carcinoma - radiotherapy | Retrospective Studies | Brain Neoplasms - radiotherapy | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms | Brain Neoplasms - diagnosis | Melanoma - radiotherapy | Treatment Outcome | Brain Neoplasms - drug therapy | Melanoma - secondary | Carcinoma, Renal Cell - radiotherapy | Analysis of Variance | Carcinoma, Renal Cell - secondary | Melanoma - drug therapy | Skin Neoplasms | Selection Bias | Aged | Combined Modality Therapy - methods | Carcinoma, Non-Small-Cell Lung - drug therapy | Care and treatment | Metastasis | Patient outcomes | Analysis | SURGERY | METASTASES | NERVOUS SYSTEM | CENTRAL NERVOUS SYSTEM | MEDICINE | NUCLEAR MEDICINE | ORGANS | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | BODY | BRAIN | RADIOLOGY
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2016, Volume 44, pp. 51 - 60
Highlights • Role of immune checkpoint inhibition in the management of key malignancies. • Description of rates of immune-related adverse events and timing of... 
Hematology, Oncology and Palliative Medicine | Pembrolizumab | Immune-related adverse events | Renal cancer | Ipilimumab | Nivolumab | Lung cancer | Melanoma | Immune-checkpoint inhibitors | OPEN-LABEL | SINGLE-ARM | ANTI-CTLA-4 ANTIBODY | METASTATIC MELANOMA | ONCOLOGY | ADVANCED MELANOMA | LONG-TERM SAFETY | MALIGNANT MESOTHELIOMA | ENTERIC NEUROPATHY | ADVERSE EVENTS | IPILIMUMAB RETREATMENT | Lung Neoplasms - drug therapy | Skin Neoplasms - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Adrenal Cortex Hormones - therapeutic use | Diarrhea - chemically induced | Infliximab - therapeutic use | Drug Eruptions - drug therapy | Antineoplastic Agents - adverse effects | Colitis - chemically induced | Antilymphocyte Serum - therapeutic use | Colitis - drug therapy | Carcinoma, Renal Cell - drug therapy | Chemical and Drug Induced Liver Injury - etiology | Pituitary Diseases - chemically induced | Pituitary Diseases - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Drug Eruptions - etiology | Neoplasms - drug therapy | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Melanoma - drug therapy | Chemical and Drug Induced Liver Injury - drug therapy | Diarrhea - drug therapy | CTLA-4 Antigen - antagonists & inhibitors | Kidney Neoplasms - drug therapy | Thyroiditis - drug therapy | Thyroiditis - chemically induced | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2017, Volume 114, Issue 19, pp. 4993 - 4998
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 2/2014, Volume 190, Issue 2, pp. 186 - 191
Journal Article
Nature (London), ISSN 1476-4687, 2016, Volume 539, Issue 7629, pp. 443 - 447
Journal Article
Cancer, ISSN 0008-543X, 2017, Volume 123, Issue 16, pp. 3040 - 3049
..., to the best of our knowledge there is limited scientific rationale and weak clinical evidence supporting treatment guidelines in this field. Therapy encompassing... 
radiotherapy | chemoradiotherapy | National Cancer Data Base (NCDB) | head and neck cancer | sinonasal malignancy | SURVIVAL | INTENSITY-MODULATED RADIOTHERAPY | CANCER | RADIATION-THERAPY | MUCOSAL MELANOMA | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | NASAL CAVITY | PARANASAL SINUS CARCINOMA | OUTCOMES | UNDIFFERENTIATED CARCINOMA | Carcinoma, Adenoid Cystic - therapy | Multivariate Analysis | Lymph Nodes - pathology | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Child, Preschool | Infant | Male | Chemoradiotherapy, Adjuvant | Young Adult | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Mucoepidermoid - therapy | Adult | Female | Neoadjuvant Therapy | Retrospective Studies | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Child | Infant, Newborn | Databases, Factual | Paranasal Sinus Neoplasms - therapy | Nose Neoplasms - pathology | Carcinoma, Adenosquamous - pathology | Carcinoma, Adenoid Cystic - pathology | Head and Neck Neoplasms - therapy | Margins of Excision | Nose Neoplasms - therapy | Proportional Hazards Models | Carcinoma, Squamous Cell - therapy | Survival Rate | Melanoma - pathology | Otorhinolaryngologic Surgical Procedures | Head and Neck Neoplasms - pathology | Carcinoma, Mucoepidermoid - pathology | Propensity Score | Paranasal Sinus Neoplasms - pathology | Carcinoma, Adenosquamous - therapy | Adolescent | Aged | Melanoma - therapy | Cancer patients | Care and treatment | Chemotherapy | Usage | Diagnosis | Radiotherapy | Cancer | Squamous cell carcinoma | Decision making | Histology | Malignancy | Radiation therapy | Multivariate analysis | Cancer therapies | Patients | Survival | Data bases | Lymph nodes | Metastases | Matching | Databases | Sinus | Surgery | Nose | Maxillary sinus | Comparative analysis | Tumors | Lymph
Journal Article